Transcriptional and epigenetic control of tissue regenerative HB-EGF in autoimmune CNS inflammation

Project Information

H I C I

Grant agreement ID: 851693

DOI

10.3030/851693

EC signature date 11 February 2020

Start date 1 March 2020

End date 28 February 2026

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost

€ 1 499 706,00

EU contribution

€ 1 499 706,00

Coordinated by

UNIVERSITATSKLINIKUM ERLANGEN
Germany

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Open Research Data Pilot (1)

Data Management Plan

Open Research Data Pilot

Publications

Peer reviewed articles (4)

Intranasal delivery of a small-molecule ErbB inhibitor promotes recovery from acute and late-stage CNS inflammation

Author(s): Mathias Linnerbauer, Lena Lößlein, Oliver Vandrey, Thanos Tsaktanis, Alexander Beer, Ulrike J Naumann, Franziska Panier, Tobias Beyer, Lucy Nirschl, Joji B Kuramatsu, Jürgen Winkler, Francisco J Quintana, Veit Rothhammer
Published in: JCI Insight, 2022, ISSN 2379-3708
Publisher: The American Society for Clinical Investigation
DOI: 10.1172/jci.insight.154824

Astrocyte-Derived Pleiotrophin Mitigates Late-Stage Autoimmune CNS Inflammation

Author(s): Mathias Linnerbauer, Lena Lößlein, Daniel Farrenkopf, Oliver Vandrey, Thanos Tsaktanis, Ulrike Naumann, Veit Rothhammer
Published in: Frontiers in Immunology, 2022, ISSN 1664-3224
Publisher: Frontiers Media SA
DOI: 10.3389/fimmu.2021.800128

Gut immune cell trafficking: inter-organ communication and immune-mediated inflammation

Author(s): Sebastian Zundler, Claudia Günther, Andreas E Kremer, Mario M Zaiss, Veit Rothhammer, Markus F Neurath
Published in: Nature Reviews Gastroenterology & Hepatology, Issue 17595053, 2022, ISSN 1759-5053
Publisher: Nature
DOI: 10.1038/s41575-022-00663-1

The Aryl Hydrocarbon Receptor-Dependent TGF-α/VEGF-B Ratio Correlates With Disease Subtype and Prognosis in Multiple Sclerosis

Author(s): Ana Cirac 1 , Thanos Tsaktanis 1 , Tobias Beyer 1 , Mathias Linnerbauer 1 , Till Andlauer 1 , Verena Grummel 1 , Lucy Nirschl 1 , Lena Loesslein 1 , Francisco J Quintana 1 , Bernhard Hemmer 1 , Veit Rothhammer 2
Published in: Neurol Neuroimmunol Neuroinflamm, 2021, ISSN 2332-7812
Publisher: American Academy of Neurology
DOI: 10.1212/nxi.0000000000001043